The first randomized trial to compare standard percutaneous coronary intervention (PCI), also known as coronary angioplasty, with PCI accompanied by the use of a temporary, miniaturized pump to ...

Patients with severe left ventricular dysfunction undergoing TAVI for aortic stenosis who experience an improvement in their ventricle’s function achieve mid-term mortality similar to that seen among ...

Nocturnal hypertension is an important predictor of the progression of left ventricular diastolic dysfunction in patients with diabetes without HF. An important predictor for the progression of left ...

Vancouver, BC - The PET and Recovery Following Revascularization (PARR-2) trial showed that, among patients with severe left ventricular (LV) dysfunction, those who received fluorodeoxyglucose (FDG) ...

High levels of inflammatory biomarkers are associated with a higher incidence of acute heart failure (HF), increased risk of readmission, and higher mortality. 1 There is also a strong correlation ...

In a 4.3-year follow-up study, few asymptomatic patients with preclinical left ventricular diastolic dysfunction (LVDD) progressed to heart failure with preserved ejection fraction (HFpEF), with a ...

The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...

PCI doesn’t reduce arrhythmia risks in patients with severe LV dysfunction and extensive coronary disease, according to a prespecified analysis of the REVIVED-BCIS2 trial. The results call into ...